Images
Participants
Contact
La Vanguardia has published an article about a research project led by IRB Barcelona and the Severo Ochoa Molecular Biology Centre that has been nominated for the "Vanguardia de la Ciencia" Award. Addressing the CPEB4 protein, the study reveals that it is a key factor in the origin of autism. The winning project will be chosen through a popular vote. The last day to vote is 28 February.
Link to La Vanguardia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
